Reply

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages 1643-1645

  Brozek, Jan L ^a   Bousquet, Jean ^b,c,d   Baena Cagnani, Carlos E ^e   Bonini, Sergio ^f,g   Canonica, G Walter ^h   Casale, Thomas B ⁱ   Van Wijk, Roy Gerth ^j   Ohta, Ken ^k   Zuberbier, Torsten ^l   Schünemann, Holger J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c INSERM   (France)

^d WHO Collaborating Center for Rhinitis and Asthma   (France)

^e UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^f INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT;

ALLERGIC RHINITIS; ASTHMA; EVIDENCE BASED PRACTICE; HAY FEVER; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 79957801358     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.01.069     Document Type: Letter

References (17)

1. Chipps B, Spector S, Farrar J, Carr W, Meltzer E, Storms W, et al. Differences in recommendations between Allergic Rhinitis and its Impact on Asthma Update 2010 and US Rhinitis Practice Parameters. J Allergy Clin Immunol 2011;127:1640-1.
2. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008;122:S1-84.
3. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
4. Spector S, Nicklas R, Blessing-Moore J, Cox L, Lang D, Randolph C, et al. Comment on Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines. J Allergy Clin Immunol 2011;127:1641-2.
5. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. (Pubitemid 351632017)
6. Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336:1106-10. (Pubitemid 351731739)
7. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ 1999;318:593-6.
8. Hussain T, Michel G, Shiffman RN. The Yale Guideline Recommendation Corpus: a representative sample of the knowledge content of guidelines. Int J Med Inform 2009;78:354-63.
9. Krahn M, Naglie G. The next step in guideline development: incorporating patient preferences. JAMA 2008;300:436-8. (Pubitemid 352040257)
10. Murad MH, Montori VM, Guyatt GH. Incorporating patient preferences in evidence-based medicine. JAMA 2008;300:2483, author reply 2484.
11. Lee TA, Pickard AS. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. Pharmacotherapy 2007;27:852-9. (Pubitemid 46849429)
12. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 2002;21:1575-600. (Pubitemid 34746064)
13. Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000;19:1707-28. (Pubitemid 30436058)
14. Portnoy JM, Van Osdol T, Williams PB. Evidence-based strategies for treatment of allergic rhinitis. Curr Allergy Asthma Rep 2004;4:439-46. (Pubitemid 39585679)
15. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992;268:240-8.
16. Oxman AD, Guyatt GH. The science of reviewing research. Ann N Y Acad Sci 1993;703:125-33, discussion 33-4.
17. Schunemann HJ, Woodhead M, Anzueto A, Buist S, Macnee W, Rabe KF, et al. A vision statement on guideline development for respiratory disease: the example of COPD. Lancet 2009;373:774-9.